Brokerages Set Perrigo Company plc (PRGO) PT at $88.42

Shares of Perrigo Company plc (NYSE:PRGO) have received an average recommendation of “Hold” from the twenty analysts that are covering the company. One investment analyst has rated the stock with a sell recommendation, thirteen have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $86.55.

Several research firms recently weighed in on PRGO. Guggenheim restated a “buy” rating and set a $125.00 price target on shares of Perrigo Company plc in a research report on Friday, December 23rd. Canaccord Genuity upped their price target on shares of Perrigo Company plc from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, February 28th. Royal Bank of Canada reduced their price target on shares of Perrigo Company plc to $68.00 in a research report on Tuesday, February 28th. Jefferies Group LLC set a $71.00 price objective on shares of Perrigo Company plc and gave the company a “hold” rating in a research note on Tuesday, February 28th. Finally, Barclays PLC dropped their price objective on shares of Perrigo Company plc from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, February 6th.

Perrigo Company plc (NYSE:PRGO) traded down 1.03% during mid-day trading on Tuesday, reaching $66.07. The company’s stock had a trading volume of 376,656 shares. The firm’s market cap is $9.47 billion. The company has a 50-day moving average price of $68.93 and a 200-day moving average price of $80.13. Perrigo Company plc has a 12-month low of $65.47 and a 12-month high of $125.80.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set Perrigo Company plc (PRGO) PT at $88.42” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/04/21/perrigo-company-plc-prgo-receives-88-42-average-pt-from-brokerages-updated.html.

Large investors have recently added to or reduced their stakes in the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Perrigo Company plc by 0.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,219 shares of the company’s stock worth $684,000 after buying an additional 36 shares during the period. Cadence Capital Management LLC raised its stake in Perrigo Company plc by 2.9% in the fourth quarter. Cadence Capital Management LLC now owns 4,138 shares of the company’s stock worth $344,000 after buying an additional 115 shares during the period. Asset Management One Co. Ltd. raised its stake in Perrigo Company plc by 0.9% in the fourth quarter. Asset Management One Co. Ltd. now owns 13,958 shares of the company’s stock worth $1,153,000 after buying an additional 131 shares during the period. Neville Rodie & Shaw Inc. raised its stake in Perrigo Company plc by 1.3% in the third quarter. Neville Rodie & Shaw Inc. now owns 11,097 shares of the company’s stock worth $1,025,000 after buying an additional 141 shares during the period. Finally, United Services Automobile Association raised its stake in Perrigo Company plc by 0.3% in the third quarter. United Services Automobile Association now owns 46,102 shares of the company’s stock worth $4,257,000 after buying an additional 156 shares during the period. Institutional investors own 69.65% of the company’s stock.

Perrigo Company plc Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

5 Day Chart for NYSE:PRGO

Receive News & Ratings for Perrigo Company plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply